Micafungin Salvage Mono-therapy in Invasive Aspergillosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Invasive Aspergillosis
Interventions
DRUG

Micafungin

IV

DRUG

Systemic antifungal therapy

IV

Trial Locations (46)

3000

Leuven

9300

Aalst

12820

Prague

21034

Dijon

28034

Madrid

28046

Madrid

77520

Olomouc

Unknown

Buenos Aires

La Plata

Brussels

Ghent

Belo Horizonte

Campinas

Curitiba

Goiânia

Ipatinga

Porto Alegre

Ribeirão Preto

Rio de Janeiro

Santo André

São Paulo

Bogotá

Bucaramanga

Santiago de Cali

Rijeka

Zagreb

Hradec Králové

Prague

Bobigny

Dijon

Paris

Pessac

Berlin

Bonn

Munich

Münster

Würzburg

Budapest

Monza

Pavia

Rozzano

Krakow

Lodz

Poznan

Salamanca

Seville

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY